MedPath

TEHRAN UNIVERSITY OF MEDICAL SCIENCES

TEHRAN UNIVERSITY OF MEDICAL SCIENCES logo
๐Ÿ‡ฎ๐Ÿ‡ทIran
Ownership
Private
Established
1934-01-01
Employees
1K
Market Cap
-
Website
http://www.tums.ac.ir

Effect of Acetazolamide & Position in CSF Leakage and Collection and Wound Dehiscence

Phase 2
Conditions
Tumor
Tethered Cord Syndrome
Lipomyelomeningocele
Dermal Sinus
Fibrolipoma of Filum Terminale
Split Cord Malformation
Interventions
Other: prone positioning
Other: Acetazolamide+ prone positioning
First Posted Date
2013-06-03
Last Posted Date
2015-04-21
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
144
Registration Number
NCT01867268
Locations
๐Ÿ‡ฎ๐Ÿ‡ท

Children'S Medical Center, Tehran, Iran, Islamic Republic of

Vapocoolant Spray Effectiveness On Arterial Puncture Pain: Randomized Double Blind Placebo-Controlled Trial

Not Applicable
Completed
Conditions
Puncture Site Pain
Interventions
Drug: Vapocoolant spray
First Posted Date
2013-05-22
Last Posted Date
2013-07-17
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
80
Registration Number
NCT01860248
Locations
๐Ÿ‡ฎ๐Ÿ‡ท

Imam Khomeini hospital complex, Tehran, Iran, Islamic Republic of

Cost Effectiveness of Glargine Insulin Versus NPH Insulin

Phase 4
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
First Posted Date
2013-04-16
Last Posted Date
2013-04-16
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
200
Registration Number
NCT01832935
Locations
๐Ÿ‡ฎ๐Ÿ‡ท

Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of

Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma

Phase 2
Completed
Conditions
Cisplatin Adverse Reaction
Upper GI Cancer
Interventions
Drug: Placebo
Drug: chemotherapy
First Posted Date
2013-04-11
Last Posted Date
2015-05-13
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
30
Registration Number
NCT01829178
Locations
๐Ÿ‡ฎ๐Ÿ‡ท

Tehran University of Medical Science, Tehran, Iran, Islamic Republic of

The Effect of GCSF in the Treatment of ALS Patients

Phase 2
Completed
Conditions
Amyotrophic Lateral Sclerosis
Interventions
First Posted Date
2013-04-05
Last Posted Date
2013-11-13
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
40
Registration Number
NCT01825551
Locations
๐Ÿ‡ฎ๐Ÿ‡ท

Iranian Neurology Research Center of Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of

Safety and Efficacy Study of a New Device for Making Neochordae in Mitral Valve Repair

Phase 1
Conditions
Mitral Valve Repair
Interventions
Device: Artificial Chordae
First Posted Date
2013-03-14
Last Posted Date
2013-03-14
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
20
Registration Number
NCT01811537

Oral Azithromycin Versus Doxycycline in Posterior Blepharitis

Phase 2
Completed
Conditions
Posterior Blepharitis
Interventions
First Posted Date
2013-02-05
Last Posted Date
2014-02-12
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
100
Registration Number
NCT01783860
Locations
๐Ÿ‡ฎ๐Ÿ‡ท

Rassoul Akram Hospital, Tehran, Iran, Islamic Republic of

Traumatic Optic Neuropathy Treatment Trial (TONTT)

Phase 1
Completed
Conditions
Traumatic Optic Neuropathy
Interventions
First Posted Date
2013-02-05
Last Posted Date
2019-05-07
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
117
Registration Number
NCT01783847
Locations
๐Ÿ‡ฎ๐Ÿ‡ท

Iran University of Medical Sciences, Tehran, Iran, Islamic Republic of

๐Ÿ‡ฎ๐Ÿ‡ท

Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of

๐Ÿ‡ฎ๐Ÿ‡ท

Beheshti University of Medical Sciences, Tehran, Iran, Islamic Republic of

Comparison of Intubation With Nerve Block and With Sedation in Awake Patients

Phase 3
Conditions
Intubation Complication
Interventions
Drug: Nerve block with Lidocain
First Posted Date
2013-01-15
Last Posted Date
2013-01-15
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
70
Registration Number
NCT01768377
Locations
๐Ÿ‡ฎ๐Ÿ‡ท

Imam Khomeini Hospital, Tehran, Iran, Islamic Republic of

Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease

Phase 2
Completed
Conditions
Non-alcoholic Fatty Liver Disease
Interventions
Drug: H.pylori eradication
First Posted Date
2013-01-03
Last Posted Date
2013-06-13
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
100
Registration Number
NCT01759628
Locations
๐Ÿ‡ฎ๐Ÿ‡ท

Gastroenterology clinic, Sina Hospital (Tehran) / Beheshti Hospital (Kashan), Tehran / Kashan, Iran, Islamic Republic of

ยฉ Copyright 2025. All Rights Reserved by MedPath